In a letter to CMS Administrator Seema Verma, Energy and Commerce Committee Chairman Frank Pallone Jr, D-New Jersey, and Ways and Means Committee Chairman Richard E. Neal, D-Massachusetts, have demanded information on the Trump administration’s changes to the federal marketplace, which they say can cause confusion for enrollees, weaken consumer protections, and further compromise the Affordable Care Act (ACA).
In a letter to CMS Administrator Seema Verma, Energy and Commerce Committee Chairman Frank Pallone Jr, D-New Jersey, and Ways and Means Committee Chairman Richard E. Neal, D-Massachusetts, demanded information on the Trump administration’s changes to the federal marketplace, which they say can cause confusion for enrollees, weaken consumer protections, and further compromise the Affordable Care Act (ACA).
The letter comes amid a legal battle in which the Trump administration is urging a federal court to strike down the entire ACA, arguing that the entire legislation is invalidated without the individual mandate.
The 2 congressmen highlighted several concerns with how a new direct enrollment process poses financial harms to consumers, including:
These concerns are heightened, they said, with CMS’ recent decision to support a new enhanced direct enrollment process, which allows consumers to enroll in coverage through a third party, such as an insurer or a web broker. In April, CMS issued a final regulation modifying the requirement applicable to direct enrollment entities, saying they were committed to enhance flixibility for consumers to enroll in coverage through third parties rather than through HealthCare.gov; the regulation is slated to go into effect June 24.
“While the private sector can play a critical role in helping to maximize enrollment in health coverage, the Trump administration should ensure that changes to the federal marketplace enrollment do not erode core consumer protections enshrined in the ACA,” they wrote. “Unfortunately, time and time again, this administration has made it more difficult for millions of consumers to access high-quality, affordable health insurance.”
Based on these concerns, the pair requested a range of information and documents by June 18, including a full list of CMS-approved direct enrollment and enhanced direct enrollment entities, any notices of intent received in connection to participation in the enhanced direct enrollment processes, information on how CMS plans to ensure consumer protections by insurance companies or web brokers, and all documents and communications relating to consumer complaints regarding the direct and enhanced direct enrollment process.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More